Antibody blood-brain barrier efflux is modulated by glycan modification

BACKGROUND: Drug delivery to the brain is a major roadblock to treatment of Alzheimer’s Disease. Recent results of the PRIME study indicate that increasing brain penetration of antibody drugs improves Alzheimer’s treatment outcomes. New approaches are needed to better accomplish this goal. Based on...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biochim Biophys Acta
Huvudupphovsmän: Finke, John M., Ayres, Kari R., Brisbin, Ryan P., Hill, Hali A., Wing, Emily E., Banks, William A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557653/
https://ncbi.nlm.nih.gov/pubmed/28624473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbagen.2017.06.008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk